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ABSTRACT
Background. Previous studies of oculomotor dysfunction in schizophrenia have tended to
concentrate on abnormalities of smooth pursuit eye tracking in chronic medicated patients. We
report the results of a study of smooth pursuit, reflexive and antisaccade performance in drug naive
and antipsychotic treated first-episode schizophrenic patients.
Methods. Smooth pursuit and saccadic eye movements were recorded in 36 first-episode
schizophrenic patients and 36 controls matched for age and estimated IQ. The schizophrenic
patients were divided into drug-naive (N¯ 17) and antipsychotic treated groups (N¯ 19).
Results. Smooth pursuit velocity gain was significantly lower than controls only in the drug-naive
patients. The treated patients did not differ significantly from either the controls or the untreated
group. In an antisaccade paradigm both treated and drug-naive schizophrenic patients demonstrated
an increased number of errors, but only drug-naive patients also demonstrated an increased latency
in initiating correct antisaccades.
Conclusions. These impairments are unlikely to be due to a generalized deficit in oculomotor
function in the schizophrenic groups, as there were no differences between the groups in saccadic
metrics on a reflexive saccade task. The results show that both smooth pursuit and saccadic
abnormalities are present at the onset of schizophrenia and are integral to the disorder.
INTRODUCTION
Oculomotor abnormalities, particularly smooth
pursuit eye tracking, are one of the most widely
studied ‘biological markers ’ of schizophrenia
(see Levy, 1994). However, several factors have
limited the utility of this research. Many early
studies used relatively insensitive electro-
oculographic recording techniques and relied on
subjective qualitative measures to rate smooth
pursuit performance. Another problem stems
from inconsistencies in methods of analysing
and measuring smooth pursuit performance,
making cross study comparison difficult. Finally,
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most studies have been performed in chronic,
medicated schizophrenic populations. It is,
therefore, possible that such oculomotor ab-
normalities may reflect either neurodegenerative
brain changes due to chronicity of illness, since
oculomotor abnormalities are witnessed in
Alzheimer’s disease (Fletcher & Sharpe, 1988)
and even healthy aged subjects (Moschner &
Baloh, 1994), or the effect of medication-related
chronic dopaminergic blockade as patients with
Parkinson’s disease also have deficits in smooth
pursuit and saccadic eye movements (Crawford
et al. 1989; Waterston et al. 1996). Indeed, some
recent evidence, with healthy volunteers, sug-
gests that smooth pursuit performance may be
adversely influenced by antipsychotic med-
ications (King, 1994; Malaspina et al. 1994).
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There are relatively few investigations meas-
uring saccadic performance in schizophrenic
patients. However, there are several reasons why
it might be important to study these in addition
to smooth pursuit. First, both systems work
together closely and interactively during normal
pursuit eye movements. Secondly, the neuro-
logical pathways involved in generating saccades
in humans are better understood than those
involved in generating smooth pursuit eye
movements. Thirdly, the basic saccadic metrics
(latency, gain, velocity, direction and final eye
position) are measured using standard pro-
cedures, allowing meaningful cross study com-
parisons. Fourthly, saccadic paradigms also
have the advantage of allowing various atten-
tional, perceptual and cognitive processes to be
selectively engaged (Henderson et al. 1996).
Finally, a number of recent studies have iden-
tified abnormalities of saccadic eye movements
in schizophrenic patients, particularly in the
antisaccade task in which subjects are required
to make a saccade to a position directly opposite
the target location (Fukushima et al. 1990;
Crawford et al. 1995a, b ; Sereno & Holzman,
1995).
In order to avoid possible contaminating
effects of medications and illness duration some
previous studies have examined smooth pursuit
performance in first-episode schizophrenic
patients (Sweeney et al. 1992; Lieberman et al.
1993; Gooding et al. 1994; Maruff et al. 1995).
These have established that smooth pursuit
abnormalities can be observed at presentation.
However, differences in the treatment status of
the patients, comparison groups and measure-
ment techniques again make conclusions as to
the exact nature of the deficit difficult to reach.
Furthermore, there are no published studies of
saccadic eye movements in first-episode schizo-
phrenic patients.
We, therefore, investigated both smooth pur-
suit and saccadic eye movements in patients
with first-episode schizophrenia in order to
examine whether these are fundamental to the
disorder. To examine the effect of antipsychotic
medication on eye movements, we compared
never medicated first-episode patients, with first-
episode patients who have received medication
for a short period of time. We use standardized
measures and a comprehensive test of smooth
pursuit (Crawford et al. 1995c) as well as two
tests of saccadic performance – the reflexive, or
prosaccade task and the antisaccade task.
METHOD
Subjects
All patients presenting to two NHS Trusts in
West London with a first-episode psychotic
illness were approached for entry into the study.
Those who agreed to participate were assessed
by a psychiatrist. Only those who fulfilled
DSM-IV criteria for schizophrenia or schizo-
phreniform disorder were included in the study.
During the first year of study 36 patients
underwent oculomotor testing and their data is
presented here. Seventeen of the patients were
completely drug-naive at the time of testing. The
remaining 19 subjects had received antipsychotic
medication for between 2 and 60 days prior to
testing. The medicated group were taking a
variety of antipsychotic drugs as the consultants
responsible for the patients treated them ac-
cording to their usual practice and were not
constrained in their choice of antipsychotic by
the study protocol. All patients provided written
informed consent. The 36 control subjects were
healthy volunteers living in the same community
who had no history of psychiatric or neurological
disorders in themselves and in their first-degree
relatives. The control subjects also denied any
history of alcohol or drug abuse. A problem
with the recording equipment during one session
lead to the results of one control subject being
lost. The characteristics of the two groups are
summarized in Table 1. The groups were
matched for sex ratio, age and estimated
pre-morbid IQ (NART; Nelson, 1982).
Apparatus
For saccadic paradigms the target display
consisted of four red light-emitting diode (LED)
targets (diameter 0±25°) located ³7±5° and ³15°
either side of a central fixation LED. The LED
Table 1. Group characteristics
N Age (range)
NART IQ
(range)
Gender
(M}F)
Control 36 25±03 (17–35) 108±84 (96–123) 21}14
Drug treated 19 25±37 (16–45) 106±85 (98–121) 15}4
Drug naive 17 27±18 (17–41) 105±62 (89–118) 12}5
P — NS NS NS
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targets were embedded in a semi-opaque screen
and were only visible when illuminated. The
smooth pursuit stimulus was a bright red laser
spot back projected onto the same translucent
screen. The target oscillated horizontally with a
triangular waveform of amplitude 22±5°.
Subjects were comfortably seated 1±5 m from
the screen with a buzzer located behind their
head. Head movements were restrained using an
adjustable head rest. All paradigms were con-
ducted in the dark. Eye movements were
recorded using a Skalar IRIS infrared limbus
reflection device. A hardware anti-aliasing filter
(cut-off frequency 200 Hz) was used to filter eye
position and the sampling rate was 500 Hz.
Stimulus display and data sampling were con-
trolled by a PDP 11}73 computer. Each para-
digm was preceded by a calibration trial in
which nine equally spaced LED targets with
known horizontal positions were illuminated
sequentially, the subject being asked to fixate
each target in turn.
Procedures
Reflexive paradigm
Each trial consisted of the following sequence:
(1) a central fixation LED was illuminated at the
beginning of each trial ; (2) after 800 ms the
fixation LED was extinguished and simul-
taneously a peripheral target LED was illumin-
ated for 1000 ms and a 200 ms buzzer signal was
initiated. Subjects were asked to direct their gaze
as quickly and as accurately as possible to the
newly illuminated target LED and then return
to the central fixation point. The order of targets
was varied pseudo-randomly to prevent pre-
dictive behaviour. There were 24 trials in all.
Antisaccade paradigm
The stimuli and procedure are identical to the
reflexive paradigm. However, the subjects are
instructed to move their eyes rapidly towards a
position in space equally distant, but in the
opposite direction to the peripheral stimulus, i.e.
to the mirror image location. An antisaccade
error occurs when the subject is ‘distracted’ by
the target appearing and makes a brief reflexive
saccade towards it. Subjects typically then make
a correct antisaccade in the opposite direction.
Subjects performed 24 trials.
In both saccadic paradigms the spatial ac-
curacy or gain (saccadic amplitude divided by
target amplitude), peak velocity and latency of
the primary saccade were measured, as well as
the final eye position (FEP). In addition, the
number of antisaccade errors made by all groups
were recorded.
Smooth pursuit
The target oscillated horizontally with a tri-
angular waveform of amplitude 22±5°. Four
velocities : 10, 20, 30 and 36°}sec were used, and
six full cycles recorded at each velocity.
Data analysis
Saccadic analysis was conducted off-line using
interactive software which enabled the rejection
of artefacts such as blinks. Eye position data
was filtered using a Kaiser window low-pass
filter. The signal was then differentiated to yield
eye velocity. Saccadic detection was based on a
velocity criterion of 30°}s in addition to an
acceleration across three consecutive samples.
Final eye position was measured by taking the
mean fixation location during the maximal
period of fixation stability after all corrected
saccades were completed.
There is considerable controversy surrounding
the various ways in which smooth pursuit
performance can be quantified (Abel & Ziegler,
1988; Friedman et al. 1995). The main function
of the pursuit system is to match the velocity of
the eyes to that of a moving target. Accordingly,
we agree with Stuve et al. (1997), that the best
assessment of the ability of the smooth pursuit
system to perform this task is reflected by the
measurement of the ratio of peak eye velocity
over target velocity, known as peak velocity
gain.
Smooth pursuit analysis was performed using
the Eyemap analysis package (Amtech GmbH,
Heidelberg). Saccadicmovementswere identified
and excluded from the analysis. In each half
cycle the portion of smooth pursuit eye move-
ment having the highest velocity was identified
and expressed as peak velocity gain (eye
velocity}target velocity). This portion was
always collected from the middle third of each
half cycle, to avoid acceleration and deceleration
transients at the beginning and end of each
ramp. Data from leftwards and rightwards
movement were kept separate, thus six velocity
values were obtained at each target velocity for
each direction of movement. For each subject
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the degree of asymmetry between leftwards (L)
and rightwards (R) was quantified as an asym-
metry factor (A) defined as
A¯
gain(R)®gain(L)
gain(R)­gain(L)
.
This factor ranges between ®1 and ­1 with a
value of zero indicating no directional pref-
erence.
Statistical analyses
Within each measure, outlying data points were
identified and removed. Outliers were defined as
values either above or below values 1±5 times the
interquartile range from the upper and lower
limits of that range (the 75th and 25th percentile
scores). This procedure resulted in the removal
of the anti-saccade error data of two control
subjects, the antisaccade latency data of two
controls and one drug-naive patient, the anti-
saccade gain data of one control, the reflexive
saccade latency data of two patients and one
control, and the smooth pursuit data of one
patient. Data were analysed with analysis of
variance (ANOVA). Where a significant main
effect of group occurred, planned comparisons
were performed. All analyses were repeated with
the outliers included and all significant effects
remained.
RESULTS
Reflexive saccades
The metrics for the reflexive saccade task are
displayed in Table 2. There were no significant
differences between any of the three groups on
primary saccade gain (F(2, 68)¯ 1±4, P" 0±5),
final eye position (F(2, 68)¯ 0±956, P" 0±5) or
latency (F(2, 65)¯ 0±14, P" 0±5).
Antisaccades
The groups differed in the number of antisaccade
errors (F(2, 66¯ 13±98, P! 0±001) (Fig. 1).
Planned comparisons revealed that both the
Table 2. Reflexive saccade metrics
Spatial
gain
Final eye
position Latency
Controls (C) 0±92 0±97 194±06
Drug treated (T) 0±87 1±00 195±80
Drug naive (N) 0±88 0±98 190±82
P NS NS NS
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Fig. 1. Antisaccade errors (bars represent standard error).
Table 3. Anti-saccade metrics : (correct trials)
Spatial
gain
Final eye
position Latency
Controls (C) ®1±07 ®1±13 302±66
Drug treated (T) ®0±84 ®1±07 295±91
Drug naive (N) ®0±99 ®1±11 352±01
P C"T NS N"C and T
drug-treated and drug-naive schizophrenics
made more antisaccade errors than controls
(t(50)¯ 5±52, P¯! 0±01 and t(48)¯ 3±68,
P! 0±01 respectively). Drug-treated schizo-
phrenics made less errors than drug-naive
patients, but the difference was not significant
(t(34)¯®1±53, P¯ 0±14). The great majority of
incorrect reflexive saccades (88±5%) were sub-
sequently corrected with antisaccades by the
schizophrenic patients.
The metrics for correct trials are displayed in
Table 3. A significant effect of group was
observed for primary saccade gain (F(2, 67)¯
3±84, P! 0±05). The gain of the primary saccade
was lower in the treated group than in the
controls (t(51)¯ 2±97, P! 0±01). The difference
between the controls and the untreated group,
and the untreated group and the treated group
were not significant (t(49)¯ 1±44, P¯ 0±16 and
t(34)¯ 0±93, P¯ 0±36). The final eye positions
did not differ significantly between groups (F(2,
68)¯ 0±19, P" 0±5). There was a significant
effect of group for correct antisaccade latency
(F(2, 65)¯ 3±72, P! 0±05). The latency to re-
spond on correct trials was significantly slower
in the untreated group than in both the treated
group (t(33)¯®2±29, P! 0±05) and the controls
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Fig. 2. Smooth pursuit velocity gain (bars represent standard
error). (U, controls ; _, drug-treated schizophrenics ; +, drug-naive
schizophrenics.)
(t(47)¯ 2±91, P! 0±01). The latencies of the
treated group and the controls did not differ
(t(50)¯®0±45, P¯ 0±65).
Smooth pursuit
The mean velocity gain at each of the four target
speeds for the three subject groups is displayed
in Fig. 2. Performance worsened with increasing
target speed for all groups, and the gain of
patientswas lower than that of controls. Analysis
of variance (ANOVA) revealed a main effect of
target speed (F(3, 201)¯ 130±21, P! 0±01) and
a main effect of group (F(2, 67)¯ 4±54,P!
0±05). The interaction was not significant
(F(6, 201)¯ 0±49). Gain was averaged across
target speeds and planned comparisons revealed
that the drug-naive group had a significantly
lower overall velocity gain than controls
(t(49)¯®3±06, P! 0±01). The gain of the drug-
treated group was not significantly different
from either the controls (t(51)¯®1±84, P¯
0±07) or from the drug-naive schizophrenics
(t(32)¯ 1±71, P¯ 0±25).
There were no differences between the groups
in the asymmetry factor (F(2, 68)¯ 1±89, P¯
0±16) with all groups showing very low mean
values (0±032, 0±041 and 0±016 for the con-
trols, drug-naive and drug-treated groups
respectively).
Relationship between measures of oculomotor
performance
Previous studies have demonstrated a relation-
ship between smooth pursuit performance and
antisaccade error rate (Sereno & Holzman, 1995;
Matsue et al. 1994). Accordingly, we performed
a Pearson correlation between the average
smooth pursuit gain and antisaccade error rate
of the patients and controls. The drug-naive and
drug-treated schizophrenic patients were com-
bined for this analysis. No significant corre-
lations were found between these two measures
in either the controls (r¯ 0±189, P¯ 0±277 or
the schizophrenic patients (r¯®0±051, P¯
0±767).
DISCUSSION
We examined smooth pursuit and saccadic eye
movements in patients with schizophrenia or
schizophreniform disorder during their first
psychotic episode. Both drug-naive and anti-
psychotic-treated patients were tested. Smooth
pursuit velocity gain was significantly lower
than controls only in the drug-naive patients. In
the antisaccade paradigm both treated and drug-
naive schizophrenic patients demonstrated an
increased number of errors. Only drug-naive
patients also demonstrated an increased latency
in initiating correct antisaccades and only drug-
treated patients had reduced primary saccade
gain compared to controls. There were no
differences between the groups on any reflexive
saccade metrics.
In the reflexive saccade task, both drug-
treated and drug-naive patients performed nor-
mally in that they were as quick as controls to
initiate an eye movement, the gain of their
primary saccades were not hypometric, and
their final eye position was highly accurate. This
suggests that they were motivated and able to
cooperate with the testing procedure. It also
suggests that other oculomotor abnormalities
cannot be ascribed to either a generalized
dysfunction of oculomotor neural systems or to
a non-specific effect of antipsychotic medication.
In the antisaccade paradigm, the patients
were, again, as accurate as controls regarding
the final eye position on correctly performed
trials, but they were impaired on other measures.
Both patient groups showed increased distract-
ibility by making more reflexive saccades (errors)
than controls. This effect was independent of
medication status and, importantly, 88±5% of
all incorrect reflexive saccades were subsequently
690 S. B. Hutton and others
corrected, indicating that errors were not due to
a misunderstanding of the paradigm. Several
studies have demonstrated an increased anti-
saccade error rate in chronic medicated patients
(Thaker et al. 1989; Fukushima et al. 1990;
Sereno & Holzman, 1995). Crawford et al.
(1995a) also found this in chronic patients who
had not received antipsychotic medication for at
least 6 months. We have now extended these
findings and demonstrated that increased anti-
saccade errors can be witnessed at the onset of
the clinical manifestations of schizophrenia, and
cannot be attributed to medication effects, to
more general problems of motivation or to a
failure to understand the experimental pro-
cedure. This saccadic oculomotor deficit, there-
fore, appears to be a fundamental abnormality
of the disorder.
Evidence suggests that volitional saccades are
under the executive control of frontal cortical
regions, including the frontal eye fields (Bruce &
Goldberg, 1985), the supplementary eye fields
(Shook et al. 1990) and the dorsolateral pre-
frontal cortex (DLPFC, Guitton et al. 1985). In
particular, DLPFC (area 46) appears to be
specifically involved in the suppression of re-
flexive saccades towards the target in antisaccade
tasks (Guitton et al. 1985; Pierrot-Deseilligny et
al. 1991). Regarding cognitive explanations of
impairment on antisaccade tasks, Henderson
and colleagues (1996) suggest that the inability
to suppress a biologically prepotent reflexive
saccade may reflect a primary deficit in strategic
planning. This explanation also agrees with
neuropsychological and functional imaging
studies of the DLPFC which have shown that
this area is critically involved in planning and
other strategic processing in non-oculomotor
tasks (Baker et al. 1996; Owen et al. 1996a, b).
There is much evidence to suggest that the
DLPFC is especially dysfunctional in schizo-
phrenic patients, and that this mediates their
abnormal performance on neuropsychological
tests of frontal lobe function such as the WCST,
and certain clinical features (see Frith, 1992,
1995).
The differences between the treated and
untreated groups on certain measures points to
a complex effect of antipsychotic medication on
performance in the antisaccade paradigm. The
treated patients were significantly faster than the
untreated patients in initiating a correct anti-
saccade suggesting that the medication was
having a beneficial effect on performance. This
effect may also account for the seemingly
reduced error rate in the treated group, although
this failed to reach statistical significance. The
significance of the decreased primary saccade
gain in the treated group is not clear. Since FEP
was normal, it does not appear to reflect a deficit
in spatial accuracy. It is interesting to note that
primary saccade hypometria has also been
observed in medicated compared to unmedicated
patients with both chronic schizophrenia and
manic psychosis (Crawford et al. 1995a, b), as
well as in patients with Parkinson’s disease
(although not on an antisaccade task, Crawford
et al. 1989). Thus, primary saccade hypometria
may be a reflection of antipsychotic drug effects
on dopaminergic extrapyramidal motor systems.
Of course, factors other than medication
might account for the differences between the
treated and untreated groups, although the
groups were matched for age, gender and
estimated IQ. However, to confirm whether our
findings are a reflection of a medication effect, or
reflect some other group difference it will be
necessary to retest the drug-naive patients once
they have been established on medication.
Smooth pursuit eye movements have been
studied much more extensively than saccadic
performance in schizophrenic patients. The
consensus opinion is that patients with chronic
schizophrenia have an impairment of smooth
pursuit eye tracking, which is perhaps best
characterized by a reduction in smooth pursuit
velocity gain (eye velocity divided by target
velocity) combined with an increase in corrective
catch up saccades (Mather, 1985; Levin et al.
1988; Moser et al. 1990; Abel et al. 1991;
Friedman et al. 1991, 1992, 1995; Litman et al.
1994). However, much of this research has been
carried out on medicated patients, and there are
a number of reasons why antipsychotic medi-
cation might be expected to effect smooth pursuit
performance. First, the abnormality witnessed
in schizophrenic patients can be mimicked by
the administration of antipsychotics to normal
volunteers (King, 1994; Malaspina et al. 1994),
although earlier studies have failed to show this
(Holzman et al. 1975). Secondly, reduced gain
has been observed in the early stages of
Parkinson’s disease (Waterston et al. 1996), in
which there is a dopamine deficiency in both the
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basal ganglia and cortex, and it is well known
that neuroleptic medication can cause parkin-
sonian symptoms in schizophrenics by blockade
of dopamine receptors. Thirdly, in chronic
patients, smooth pursuit is worse in those
currently taking antipsychotic medication com-
pared to those who have been off medication for
at least 6 months (Crawford et al. 1995b ;
Kufferle et al. 1990), although studies with
shorter wash-out periods have failed to dem-
onstrate this (Siever et al. 1986; Spohn et al.
1988).
Two previous studies have therefore examined
smooth pursuit in drug-naive patients. Campion
et al. (1992) were the first to show that drug-
naive patients were as equally impaired as
medicated patients. Subsequently, Sweeney and
colleagues (1994) demonstrated that drug-naive
and drug-free, but previously treated groups of
schizophrenic patients had equally reduced
smooth pursuit gain compared with controls
and that there was no change in this measure
following drug therapy in either group. How-
ever, the patients in this study had been ill for a
mean of 2 years and those of Campion for a
mean of 4 years. Studies specifically examining
smooth pursuit at the onset of psychosis confirm
the presence of reduced velocity gain, but these
results are confounded by the inclusion of both
treated and untreated patients (Sweeney et al.
1992; Lieberman et al. 1993). The present study,
therefore, clarifies these issues by the dem-
onstration that first-episode drug-naive patients
have reduced smooth pursuit velocity gain thus
confirming and extending the above findings.
A number of cortical areas are believed to be
involved in the control of smooth pursuit eye
movements, including the medial temporal visual
area (MT) and medial superior temporal visual
area (MST), the posterior parietal cortex (PPC)
and the frontal eye fields (FEF). It is believed
that area MST combines the target motion
information with an internally generated signal
of eye velocity. The role of the PPC is presumed
to be attentional, whereas the FEF may be
involved in programming predictive pursuit
movements (MacAvoy et al. 1991; Morrow &
Sharpe, 1995). The frontal eye fields are also
believed to be important in antisaccade per-
formance (Rivaud et al. 1994; Pierrot-
Deseilligny et al. 1995). Previous research has
found that subjects with poor pursuit tracking
also make more antisaccade errors (Matsue et
al. 1994; Sereno & Holzman, 1995). These
findings have been used as further evidence for
the contention that schizophrenia is a ‘ frontal ’
impairment. However, in our study no such
relationship between performance on the two
tasks was observed, a result consistent with
Gooding et al. (1997). These findings, therefore,
imply that schizophrenic patients are failing the
tasks for different reasons and that different
pathophysiological mechanisms may underlie
the impairment on these two types of task. We
are currently conducting research aimed at
further exploring different cognitive deficits
which may contribute to low smooth pursuit
velocity gain and increased antisaccade error
rate in schizophrenic patients.
This study was supported by Wellcome grant number
042025.
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